# Johnson & Johnson (JNJ) cash on hand: $20.10B in 2025

URL: https://funkfolio.com/stock/JNJ/cash

> Johnson & Johnson (JNJ) cash on hand was $20.10B at the end of fiscal 2025, down 18.0% from fiscal 2024. Year-by-year chart and table.

---

## Johnson & Johnson (JNJ) cash on hand

**Cash · fiscal 2025:** $20.10B at Dec 31, 2025

Johnson & Johnson (JNJ) held cash of $20.10B at the end of fiscal 2025 (December 31, 2025). That is 18.0% lower than the $24.52B of fiscal 2024. Figures as of 18 Nov 2026, 04:41 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Cash, fiscal 2025:** $20.10B
- **Change on fiscal 2024:** −18.0%
- **Highest on record:** $24.52B fiscal 2024
- **Lowest on record:** $20.10B fiscal 2025
- **Fiscal years on record:** 4 2022–2025

Figures as of 18 Nov 2026, 04:41 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Johnson & Johnson cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $24.52B in fiscal 2024 and the lowest $20.10B in fiscal 2025.

### Cash by fiscal year

### Johnson & Johnson cash on hand, year by year

Johnson & Johnson (JNJ) cash on hand by fiscal year

| Fiscal year | Cash | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $20.10B | 18.0% down | Dec 31, 2025 |
| 2024 | $24.52B | 7.0% up | Dec 31, 2024 |
| 2023 | $22.93B | 2.9% up | Dec 31, 2023 |
| 2022 | $22.28B | — | Dec 31, 2022 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

### How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

### Cash at health care companies of similar size

Cash of Johnson & Johnson and comparable companies

| Company | Cash | Fiscal year |
| --- | --- | --- |
| [Eli Lilly LLY](https://funkfolio.com/stock/LLY/cash) | $7.27B | 2025 |
| Johnson & Johnson JNJ | $20.10B | 2025 |
| [AbbVie ABBV](https://funkfolio.com/stock/ABBV/cash) | $5.26B | 2025 |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/cash) | $14.57B | 2025 |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/cash) | $28.12B | 2025 |
| [Novartis NVS](https://funkfolio.com/stock/NVS/cash) | $11.53B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Johnson & Johnson, figure by figure

- [Johnson & Johnson market cap](https://funkfolio.com/stock/JNJ/market-cap)
- [Johnson & Johnson revenue](https://funkfolio.com/stock/JNJ/revenue)
- [Johnson & Johnson earnings](https://funkfolio.com/stock/JNJ/earnings)
- [Johnson & Johnson earnings per share (EPS)](https://funkfolio.com/stock/JNJ/eps)
- [Johnson & Johnson P/E ratio](https://funkfolio.com/stock/JNJ/pe-ratio)
- [Johnson & Johnson P/S ratio](https://funkfolio.com/stock/JNJ/ps-ratio)
- [Johnson & Johnson P/B ratio](https://funkfolio.com/stock/JNJ/pb-ratio)
- [Johnson & Johnson free cash flow](https://funkfolio.com/stock/JNJ/free-cash-flow)
- [Johnson & Johnson operating margin](https://funkfolio.com/stock/JNJ/operating-margin)
- [Johnson & Johnson dividend](https://funkfolio.com/stock/JNJ/dividend)
- [Johnson & Johnson shares outstanding](https://funkfolio.com/stock/JNJ/shares-outstanding)
- [Johnson & Johnson total debt](https://funkfolio.com/stock/JNJ/total-debt)
- [Johnson & Johnson total assets](https://funkfolio.com/stock/JNJ/total-assets)
- [Johnson & Johnson return on equity (ROE)](https://funkfolio.com/stock/JNJ/roe)
- [Johnson & Johnson return on invested capital (ROIC)](https://funkfolio.com/stock/JNJ/roic)

[Johnson & Johnson (JNJ) overview: price, valuation and scorecard](https://funkfolio.com/stock/JNJ) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Johnson & Johnson cash on hand: questions and answers

**How much cash does Johnson & Johnson have?**

Johnson & Johnson (JNJ) held cash of $20.10B at the end of fiscal 2025 (December 31, 2025). That is 18.0% lower than the $24.52B of fiscal 2024.

**What are the highest and lowest cash figures on record for Johnson & Johnson?**

Across the 4 fiscal years on record (2022–2025), the highest was $24.52B in fiscal 2024 and the lowest $20.10B in fiscal 2025.

**How is Johnson & Johnson's cash calculated?**

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

### Learn: cash on hand

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Johnson & Johnson (JNJ) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/JNJ/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.
